These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21566511)

  • 1. Intracytoplasmic lipid accumulation in apocrine carcinoma of the breast evaluated with adipophilin immunoreactivity: a possible link between apocrine carcinoma and lipid-rich carcinoma.
    Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Shiraiwa M; Nishida C; Morita T; Sato Y; Hayashi T; Kato A
    Am J Surg Pathol; 2011 Jun; 35(6):861-7. PubMed ID: 21566511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perilipin and adipophilin expression in sebaceous carcinoma and mimics.
    Boussahmain C; Mochel MC; Hoang MP
    Hum Pathol; 2013 Sep; 44(9):1811-6. PubMed ID: 23642680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apocrine differentiation in invasive pleomorphic lobular carcinoma with in situ ductal and lobular apocrine carcinoma: case report.
    Kaya H; Aribal E; Yegen C
    Pathol Oncol Res; 2002; 8(2):151-2. PubMed ID: 12172583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous and mammary apocrine carcinomas have different immunoprofiles.
    Piris A; Peng Y; Boussahmain C; Essary LR; Gudewicz TM; Hoang MP
    Hum Pathol; 2014 Feb; 45(2):320-6. PubMed ID: 24342430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
    Tramm T; Kim JY; Tavassoli FA
    Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uroplakin II Expression in Breast Carcinomas Showing Apocrine Differentiation: Putting Some Emphasis on Invasive Pleomorphic Lobular Carcinoma as a Potential Mimic of Urothelial Carcinoma at Metastatic Sites.
    Tajima S; Koda K
    Dis Markers; 2016; 2016():2940496. PubMed ID: 27642214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed pleomorphic lobular and apocrine carcinoma of the breast: A case report suggesting pathogenesis.
    Ishii A; Oishi T; Kakuda Y; Yasui H; Kawata T; Muramatsu K; Takahashi K; Sugino T
    Pathol Int; 2019 May; 69(5):288-293. PubMed ID: 30811750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apocrine differentiation in human mammary carcinoma.
    Mossler JA; Barton TK; Brinkhous AD; McCarty KS; Moylan JA; McCarty KS
    Cancer; 1980 Dec; 46(11):2463-71. PubMed ID: 6254632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining for adipophilin, perilipin and TIP47.
    Muthusamy K; Halbert G; Roberts F
    J Clin Pathol; 2006 Nov; 59(11):1166-70. PubMed ID: 16556662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
    Bratthauer GL; Saenger JS; Strauss BL
    Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast.
    D'Arcy C; Quinn C
    J Clin Pathol; 2019 Jan; 72(1):1-6. PubMed ID: 30409840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
    Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
    APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of immunohistochemistry in the differential diagnosis of breast lesions.
    Moriya T; Kozuka Y; Kanomata N; Tse GM; Tan PH
    Pathology; 2009 Jan; 41(1):68-76. PubMed ID: 19089742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
    Kővári B; Báthori Á; Cserni G
    Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic and granular cell tumors of the breast.
    Damiani S; Dina R; Eusebi V
    Semin Diagn Pathol; 1999 May; 16(2):117-25. PubMed ID: 10452577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
    Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation.
    Nakamura H; Kukita Y; Kunimasa K; Kittaka N; Kusama H; Nakayama T; Tamaki Y; Sugiura R; Yasuda H; Hashimoto M; Yamamoto T; Imamura F; Nakatsuka SI
    Hum Pathol; 2021 Oct; 116():39-48. PubMed ID: 34314764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.